Form 4: Labcorp Executive Reports Stock Transactions

Sandra D. van der Vaart, EVP and Chief Legal Officer of Labcorp Holdings Inc., reports transactions involving common stock and stock options.

Summary

• On February 11, 2025, Sandra D. van der Vaart, EVP and Chief Legal Officer of Labcorp Holdings Inc., reported transactions involving the company's stock.
• These transactions included the acquisition of 323 shares of common stock through the vesting of restricted stock units and the withholding of 86 shares for tax obligations.
• Van der Vaart also acquired 3,400 non-qualified stock options with an exercise price of $245.14, vesting in three equal annual installments beginning on February 11, 2026, and expiring on February 10, 2035.
• Additionally, 1,130 restricted stock units were acquired, vesting in three equal annual installments beginning on February 11, 2026.
• Following these transactions, van der Vaart directly owns 3,484.5397 shares of common stock, 3,400 non-qualified stock options, and 2,257 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing and does not convey any particular sentiment. It simply reports transactions.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is a common practice among publicly traded companies. It provides transparency into the executive's holdings and transactions in the company's stock.

Stakeholder Impact

• The transactions reported may be of interest to shareholders as they provide insight into the executive's stake in the company.
• The transactions have no immediate impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Form 4, Insider Trading, Stock Options, Restricted Stock Units, LABCORP HOLDINGS INC., LH, Sandra D. van der Vaart, Executive Compensation, Beneficial Ownership